DiscoverThe Pharma PodcastPMPRB New Guidelines Affecting Drug Pricing in Canada
PMPRB New Guidelines Affecting Drug Pricing in Canada

PMPRB New Guidelines Affecting Drug Pricing in Canada

Update: 2021-02-02
Share

Description

On this episode of The Pharma Podcast my guest is Lindy Forte, Senior Partner, Health Technology Assessment at Accelera Canada .

Lindy discusses the Patented Medicines Pricing Review Board (PMPRB),  the amendments to the Patented Medicines Regulations and its impact on Drug prices in Canada.

She also shares her thoughts on what she likes about the new regulations, and some potential shortcomings.

This episode of the podcast is a must listen to for any pharma professional considering launching a new drug in Canada.

Contact Information:
www.acceleracanada.com
lindy.forte@acceleracanada.com

Comments 
In Channel
loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

PMPRB New Guidelines Affecting Drug Pricing in Canada

PMPRB New Guidelines Affecting Drug Pricing in Canada

Lindy Forte